StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Services Revenue — Note 6 by Quarter

Services Revenue — Note 6 ($M)

QuarterlyAnnual

Thermo Fisher Scientific Services Revenue — Note 6: $5,171M in Q2 2026, up 12.3% from a year earlier. That is the highest of the 28 quarters on record here.

Latest, Q2 2026
5,171
Period ended Jun 30, 2026
Change on a year earlier
+12.3%
4,605 in Q2 2025
History
28 quarters
Since Q3 2019
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Services | 5,171 | 4,605 | 9,899 | 8,990”

Source: SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗

Revenue from clinical research services (PPD), contract pharmaceutical manufacturing (Patheon), and instrument technical services. Q4 = FY − 9M.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedServices Revenue — Note 6 ($M)Year on yearSource
Q2 2026Jun 30, 20265,171+12.3%SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Q1 2026Mar 31, 20264,728+7.8%SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗
Q4 2025Dec 31, 20254,969+7.4%SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Q3 2025Sep 30, 20254,633+4.1%SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗
Q2 2025Jun 30, 20254,605+5.2%SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Q1 2025Mar 31, 20254,384-0.1%SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗
Q4 2024Dec 31, 20244,627+3.4%SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Q3 2024Sep 30, 20244,450+0.7%SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗
Q2 2024Jun 30, 20244,378-0.9%SEC Form 10-Q (10q_2025Q2, filed 2025-08-01) ↗
Q1 2024Mar 31, 20244,390+2.0%SEC Form 10-Q (10q_2025Q1, filed 2025-05-02) ↗
Q4 2023Dec 31, 20234,475-0.7%SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Q3 2023Sep 30, 20234,417+7.9%SEC Form 10-Q (10q_2024Q3, filed 2024-11-01) ↗
Q2 2023Jun 30, 20234,416+11.3%SEC Form 10-Q (10q_2024Q2, filed 2024-08-02) ↗
Q1 2023Mar 31, 20234,306+13.3%SEC Form 10-Q (10q_2024Q1, filed 2024-05-03) ↗
Q4 2022Dec 31, 20224,505+62.6%SEC Form 10-K (10k_2024, filed 2025-02-20) ↗
Q3 2022Sep 30, 20224,094+107.8%SEC Form 10-Q (10q_2023Q3, filed 2023-11-03) ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Services Revenue — Note 6 ($M), quarterly Q3 2019–Q2 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-type-services

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.